Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People's Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates serie… Read more
Apeloa Pharmaceutical Co Ltd (000739) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.056x
Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) has a cash flow conversion efficiency ratio of 0.056x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥366.84 Million) by net assets (CN¥6.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Apeloa Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Apeloa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Apeloa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apeloa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
De'Longhi S.p.A
OTCGREY:DELHF
|
-0.041x |
|
Fagron NV
OTCGREY:ARSUF
|
0.043x |
|
Corporativo GBM S.A.B. de C.V
MX:GBMO
|
-0.065x |
|
The Gunma Bank Ltd
OTCGREY:GMBKF
|
N/A |
|
Fabege AB
ST:FABG
|
0.023x |
|
Amprius Technologies Inc.
NYSE:AMPX
|
-0.090x |
|
Chemring Group PLC
PINK:CMGMF
|
0.134x |
|
Asker Healthcare
ST:ASKER
|
0.068x |
Annual Cash Flow Conversion Efficiency for Apeloa Pharmaceutical Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Apeloa Pharmaceutical Co Ltd from 1998 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.75 Billion | CN¥1.21 Billion | 0.179x | +8.18% |
| 2023-12-31 | CN¥6.23 Billion | CN¥1.03 Billion | 0.166x | -31.10% |
| 2022-12-31 | CN¥5.52 Billion | CN¥1.33 Billion | 0.240x | +98.74% |
| 2021-12-31 | CN¥5.06 Billion | CN¥611.75 Million | 0.121x | -49.90% |
| 2020-12-31 | CN¥4.39 Billion | CN¥1.06 Billion | 0.241x | -33.15% |
| 2019-12-31 | CN¥3.77 Billion | CN¥1.36 Billion | 0.361x | +44.97% |
| 2018-12-31 | CN¥3.34 Billion | CN¥832.69 Million | 0.249x | +261.97% |
| 2017-12-31 | CN¥3.05 Billion | CN¥209.80 Million | 0.069x | -0.24% |
| 2016-12-31 | CN¥2.62 Billion | CN¥180.42 Million | 0.069x | -62.22% |
| 2015-12-31 | CN¥2.42 Billion | CN¥441.16 Million | 0.183x | -46.49% |
| 2014-12-31 | CN¥2.31 Billion | CN¥786.64 Million | 0.341x | +232.78% |
| 2013-12-31 | CN¥1.86 Billion | CN¥190.45 Million | 0.103x | -58.33% |
| 2012-12-31 | CN¥1.37 Billion | CN¥335.90 Million | 0.246x | +9.18% |
| 2011-12-31 | CN¥806.67 Million | CN¥181.74 Million | 0.225x | +50.49% |
| 2010-12-31 | CN¥808.57 Million | CN¥121.05 Million | 0.150x | -42.88% |
| 2009-12-31 | CN¥794.78 Million | CN¥208.30 Million | 0.262x | +112.87% |
| 2008-12-31 | CN¥768.11 Million | CN¥94.57 Million | 0.123x | -46.98% |
| 2007-12-31 | CN¥750.11 Million | CN¥174.20 Million | 0.232x | -33.61% |
| 2006-12-31 | CN¥455.77 Million | CN¥159.43 Million | 0.350x | +64.87% |
| 2005-12-31 | CN¥411.93 Million | CN¥87.40 Million | 0.212x | +65.59% |
| 2004-12-31 | CN¥371.08 Million | CN¥47.54 Million | 0.128x | -60.01% |
| 2003-12-31 | CN¥328.83 Million | CN¥105.36 Million | 0.320x | +3160.50% |
| 2002-12-31 | CN¥286.40 Million | CN¥2.81 Million | 0.010x | +547.91% |
| 2001-12-31 | CN¥259.70 Million | CN¥-569.79K | -0.002x | -109.77% |
| 2000-12-31 | CN¥315.13 Million | CN¥7.08 Million | 0.022x | +133.71% |
| 1999-12-31 | CN¥307.93 Million | CN¥-20.52 Million | -0.067x | -154.92% |
| 1998-12-31 | CN¥248.02 Million | CN¥30.10 Million | 0.121x | -- |